Exemestane

Exemestane Struktur
107868-30-4
CAS-Nr.
107868-30-4
Englisch Name:
Exemestane
Synonyma:
AROMASIN;EXALAMIDE;Exemestan;ExeMestane(AroMasin);EXE;ROMASIN;PNU155971;FCE-24304;ExeMestine;EXEMESTANE
CBNumber:
CB5760314
Summenformel:
C20H24O2
Molgewicht:
296.4
MOL-Datei:
107868-30-4.mol

Exemestane Eigenschaften

Schmelzpunkt:
155.13°C
Siedepunkt:
453.7±45.0 °C(Predicted)
Dichte
1.13±0.1 g/cm3(Predicted)
storage temp. 
2-8°C
Löslichkeit
DMSO: ≥20mg/mL
Aggregatzustand
powder
Farbe
white to off-white
Optische Aktivität
[α]/D +250 to +300°, c = 1 in methanol
InChI
InChI=1S/C20H24O2/c1-12-10-14-15-4-5-18(22)20(15,3)9-7-16(14)19(2)8-6-13(21)11-17(12)19/h6,8,11,14-16H,1,4-5,7,9-10H2,2-3H3/t14-,15-,16-,19+,20-/m0/s1
InChIKey
BFYIZQONLCFLEV-DAELLWKTSA-N
SMILES
C1(=O)C=C2[C@](C)(C=C1)[C@]1([H])[C@]([H])([C@@]3([H])[C@@](CC1)(C)C(=O)CC3)CC2=C
CAS Datenbank
107868-30-4(CAS DataBase Reference)
Sicherheit
  • Risiko- und Sicherheitserklärung
  • Gefahreninformationscode (GHS)
Kennzeichnung gefährlicher T,N
R-Sätze: 60-61-51
S-Sätze: 53-22-36/37-57
WGK Germany  3
HS Code  29372900
Giftige Stoffe Daten 107868-30-4(Hazardous Substances Data)
Bildanzeige (GHS) GHS hazard pictogramsGHS hazard pictograms
Alarmwort Achtung
Gefahrenhinweise
Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code
H360 Kann die Fruchtbarkeit beeinträchtigen oder das Kind im Mutterleib schädigen. Fertility (Fruchtbarkeit) Kategorie 1 Achtung GHS hazard pictogramssrc="/GHS08.jpg" width="20" height="20" />
H411 Giftig für Wasserorganismen, mit langfristiger Wirkung. Langfristig (chronisch) gewässergefährdend Kategorie 2
Sicherheit
P201 Vor Gebrauch besondere Anweisungen einholen.
P202 Vor Gebrauch alle Sicherheitshinweise lesen und verstehen.
P273 Freisetzung in die Umwelt vermeiden.
P280 Schutzhandschuhe/Schutzkleidung/Augenschutz tragen.
P308+P313 BEI Exposition oder falls betroffen: Ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.
P391 Verschüttete Mengen aufnehmen.

Exemestane Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung

Exemestane was launched in US and other countries for the treatment of estrogendependent tumors and postmenopausal breast cancer. It is a novel steroidal compound structurally related to the natural substrate for the biosynthesis of estrogen, androstanedione, and can be synthesized by methylidenation of androsta-1, 4-dien- 17beta-ol-3-one in 6 position then oxidation of the alcohol function. Exemestane is an irreversible inactivator of the aromatase enzyme system, so inducing in vivo a dose-related sustained suppression of serum estrogen and minimal endocrine activity. It is the first steroidal representative of the third-generation of orally active aromatase inhibitors with a highly potent and selective mechanism of action, displaying good tolerability and safety profile. In rats with DMBA-induced mammary tumors, 10 to 100 mglkg of exemestan administered po twice-daily for 4 weeks resulted in 76 to 88% regression. In women failing anti-estrogen therapy with tamoxifen, this agent has demonstrated high activity in locally advanced or metastatic disease. In addition, it may also have potential for breast cancer prevention.

Chemische Eigenschaften

white to light yellow crystal powder

Verwenden

Labeled Exemestane, intended for use as an internal standard for the quantification of Exemestane by GC- or LC-mass spectrometry.

Definition

ChEBI: A 17-oxo steroid that is androsta-1,4-diene-3,17-dione in which the hydrogens at position 6 are replaced by a double bond to a methylene group. A selective inhibitor of the aromatase (oestrogen synthase) system, it is used in the treatment of advanced brea t cancer.

Allgemeine Beschreibung

Exemestane, 6-methylenandrosta-1,4-diene-3,17-dione (Aromasin), is the first steroid-basedaromatase inhibitor approved for the treatment of breastcancer in the United States. It is a mechanism-based inactivatorthat irreversibly inhibits the enzyme. Plasma estrogenlevels are reduced by 85% to 95% within 2 to 3 days, and effectslast 4 to 5 days. Exemestane does not inhibit any of themajor cytochromes P450 and has essentially no interactionwith steroid receptors, with only a very weak affinity for theAR. The 17β-hydroxyexemestane reduction product, however,has much higher affinity for the AR than the parent(still several fold less than DHT, 0.28% for parent vs. 30%for metabolite). The clinical significance of the affinity islikely minimal because of the low levels of the metaboliteproduced.

Hazard

A reproductive hazard.

Exemestane Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Exemestane Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 572)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Shanghai Longyu Biotechnology Co., Ltd.
+8615821988213
info@longyupharma.com China 2531 58
Changzhou Xuanming Pharmaceutical Technology Co., Ltd.
+8618068519287
sales@xuanmingchem.com China 820 58
Zhejiang J&C Biological Technology Co.,Limited
+1-2135480471 +1-2135480471
sales@sarms4muscle.com China 10523 58
qingdao future trading Co., Ltd
+86-13335044410 +86-13335044410
cui56813@163.com China 110 58
Hong Kong Excellence Biotechnology Co., Ltd.
+86-86-18838029171 +8618126314766
ada@sh-teruiop.com China 892 58
Shanghai Getian Industrial Co., LTD
+undefined15373193816
mike@ge-tian.com China 272 58
Guangdong Tuoyuan Biotechnology Co., LTD
+85267545345
sterodschina@gmail.com China 102 58
Hebei Mojin Biotechnology Co., Ltd
+8613288715578
sales@hbmojin.com China 12453 58
Hebei Yanxi Chemical Co., Ltd.
+8617531190177
peter@yan-xi.com China 5993 58
Anhui Zhongda Biotechnology Co., Ltd
+8619956560829
justine@zhongda-biotech.com China 300 58

107868-30-4()Verwandte Suche:


  • ExeMestane (USP)
  • 1,4-Androstadien-3,17-dione-6-Methylene-d2
  • (8R,9S,10R,13S,14S)-10,13-Dimethyl-6-methylene-7,8,9,11,12,13,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17(10H,14H)-dione
  • ExeMestine
  • (8R,9S,10R,13S,14S)-10,13-diMethyl-6-Methylene-7,8,9,10,11,12,13,14,15,16-decahydro-3H-cyclopenta[a]phenanthrene-3,17(6H)-dione
  • ExeMestane SynonyMs 6-Methylenandrosta-1,4-diene-3,17-dione
  • PNU155971
  • Exemestane for system suitability
  • Exemestance:6-methyleneandrosta-1,4-diene-3,17-dione
  • Exemestane D2
  • 6-methylenandrosta-1,4-diene-3,17-dione
  • 6-METHYLENEANDROSTA-1,4-DIENE-3,17-DIONE
  • Exemestance
  • 10,13-dimethyl-6-methylidene-7,8,9,10,11,12,13,14,15,16-decahydrocyclopenta[a]phenanthrene-
  • EXEMESTANE
  • FCE-24304
  • Androsta-1,4-diene-3,17-dione, 6-methylene
  • 6-Methyleneandrosta-1,4-diene-3,17-dione, FCE-24304, Aromasin
  • FCE24304;FCE-24304
  • Exemestane(FCE 24304)
  • 10,13-dimethyl-6-methylene-7,8,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,17-dione
  • Exemestane - Aromasin | FCE 24304
  • Exemestone
  • EXE
  • Aromasin/exemestane
  • Aromasin CAS 107868-30-4
  • Exemestane CRS
  • Exemestane for system suitability CRS
  • [2H2]-Exemestane
  • Aromasin Exeme Acatate?
  • Exemestane USP/EP/BP
  • Steroids Raw Powder Hormone Exemestane, Aromasin
  • Exemestane(USFDA/CEP)
  • ROMASIN
  • Exemestane (Aromasin,EXE)-1 gram(17)
  • ExemestaneQ: What is Exemestane Q: What is the CAS Number of Exemestane Q: What is the storage condition of Exemestane Q: What are the applications of Exemestane
  • Exemestane for system suitability (Y0001756)
  • Exemestane 13C D2Q: What is Exemestane 13C D2 Q: What is the CAS Number of Exemestane 13C D2 Q: What is the storage condition of Exemestane 13C D2 Q: What are the applications of Exemestane 13C D2
  • Exemestane D2Q: What is Exemestane D2 Q: What is the CAS Number of Exemestane D2 Q: What is the storage condition of Exemestane D2 Q: What are the applications of Exemestane D2
  • Exemestane (1269050)
  • ExeMestane(AroMasin)
  • Exemestan
  • AROMASIN
  • EXALAMIDE
  • Exemestane 107868-30-4
  • Aromasin / Exemestan / Exemestane
  • Aromasin, or Exemestane
  • 107868-30-4
  • 156-1-31
  • 7868-30-4
  • 107968-30-4
  • C20H24O2
  • 2964
  • Intermediates & Fine Chemicals
  • Pharmaceuticals
  • Steroids
  • Pfizer compounds
  • Steroid and Hormone
Copyright 2019 © ChemicalBook. All rights reserved